Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3)
Brazil · Delayed Price · Currency is BRL 8.86
-0.08 (-0.89%)
Oct 7, 2026, 5:04 PM GMT-3
BVMF:PFRM3 Ratios and Metrics
Market cap in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,086 | 1,119 | 796 | 748 | 450 | 723 | |
Market Cap Growth | 19.09% | 40.68% | 6.39% | 66.21% | -37.80% | -3.28% |
Enterprise Value | 2,739 | 2,443 | 2,018 | 1,935 | 1,700 | 1,929 |
Last Close Price | 8.86 | 8.81 | 5.79 | 5.06 | 2.99 | 4.61 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 7.03 | 9.41 | 6.95 | 10.62 | 5.56 | 9.25 |
Forward PE | - | 13.03 | 13.03 | 13.03 | 13.03 | 13.03 |
PS Ratio | 0.09 | 0.10 | 0.08 | 0.09 | 0.06 | 0.11 |
PB Ratio | 0.64 | 0.68 | 0.50 | 0.49 | 0.30 | 0.49 |
P/TBV Ratio | 1.46 | 1.58 | 1.18 | 1.19 | 0.79 | 1.57 |
P/FCF Ratio | 2.65 | 3.58 | 2.02 | 3.87 | 6.78 | 18.53 |
P/OCF Ratio | 1.90 | 2.44 | 1.60 | 2.87 | 3.56 | 6.73 |
PEG Ratio | - | 0.86 | 0.86 | 0.86 | 0.86 | 0.86 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.22 | 0.21 | 0.20 | 0.22 | 0.22 | 0.30 |
EV/EBITDA Ratio | 4.95 | 6.04 | 5.90 | 6.55 | 6.22 | 11.85 |
EV/EBIT Ratio | 7.47 | 6.98 | 6.74 | 7.41 | 7.00 | 14.16 |
EV/FCF Ratio | 6.69 | 7.80 | 5.12 | 10.01 | 25.61 | 49.40 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.13 | 0.86 | 0.79 | 0.74 | 0.68 | 0.64 |
Debt / EBITDA Ratio | 3.43 | 2.64 | 2.75 | 2.90 | 2.79 | 3.81 |
Debt / FCF Ratio | 4.63 | 4.48 | 3.16 | 5.92 | 15.43 | 24.25 |
Net Debt / Equity Ratio | 0.84 | 0.71 | 0.64 | 0.62 | 0.56 | 0.51 |
Net Debt / EBITDA Ratio | 3.33 | 2.88 | 2.97 | 3.21 | 3.08 | 4.66 |
Net Debt / FCF Ratio | 3.44 | 3.73 | 2.58 | 4.91 | 12.67 | 19.42 |
Asset Turnover | 1.87 | 1.93 | 1.92 | 1.86 | 1.86 | 1.65 |
Inventory Turnover | 5.62 | 4.95 | 5.16 | 5.33 | 5.75 | 5.54 |
Quick Ratio | 0.79 | 0.68 | 0.70 | 0.81 | 0.88 | 0.86 |
Current Ratio | 1.37 | 1.29 | 1.35 | 1.45 | 1.52 | 1.50 |
Return on Equity (ROE) | 9.75% | 7.82% | 7.86% | 5.11% | 5.70% | 5.44% |
Return on Assets (ROA) | 3.44% | 3.69% | 3.55% | 3.51% | 3.62% | 2.19% |
Return on Invested Capital (ROIC) | 10.57% | 12.96% | 11.30% | 10.29% | 10.60% | 6.49% |
Return on Capital Employed (ROCE) | 9.60% | 12.70% | 11.40% | 10.50% | 10.10% | 5.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 14.23% | 10.62% | 14.40% | 9.41% | 17.97% | 10.81% |
FCF Yield | 37.71% | 27.96% | 49.58% | 25.85% | 14.75% | 5.40% |
Dividend Yield | 6.49% | - | 9.92% | 7.62% | 5.79% | 5.87% |
Payout Ratio | 51.12% | 33.64% | - | 44.36% | - | 37.24% |
Total Shareholder Return | 6.49% | - | 9.92% | 7.62% | 5.79% | 5.87% |